12/01/1996 - "The influence of central monoamine modifications on tolycaine-induced convulsions was also examined. "
12/01/1996 - "Pharmacological analysis of local anaesthetic tolycaine-induced convulsions by modification of monoamines in rat brain."
12/01/1996 - "These results suggest that brain noradrenaline and 5-hydroxytryptamine are major regulators in the tolycaine-induced convulsive process and that central catecholaminergic neurones act in a stimulatory way on the tolycaine-induced convulsions, while serotonergic neurones act suppressively."
12/01/1996 - "Pretreatment with alpha-methyl-p-tyrosine, which depletes brain catecholamine, suppresses the tolycaine-induced convulsions, as shown by a decrease in the incidence; L-3,4-dihydroxyphenylalanine and bis-(1-methyl-4-homopiperazinyl-thiocarbonyl)-disulfide, which increase brain catecholamine, intensified the convulsions, as shown by shortening of the latency and increase in the mortality. "
|2.||Serotonin (5 Hydroxytryptamine)
|4.||Levodopa (L Dopa)